193 related articles for article (PubMed ID: 19864027)
21. Effect of a novel fully human monovalent antigen-binding fragment on the survival of cancer cell lines.
Kwon YS; Lee YR; Kim YS; Lee HW; Jang YJ
Oncol Rep; 2007 Aug; 18(2):513-7. PubMed ID: 17611678
[TBL] [Abstract][Full Text] [Related]
22. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
Mitsiades N; Poulaki V; Mitsiades C; Tsokos M
Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Wang X; Campoli M; Ko E; Luo W; Ferrone S
J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
[TBL] [Abstract][Full Text] [Related]
24. Humanization of agonistic anti-human 4-1BB monoclonal antibody using a phage-displayed combinatorial library.
Son JH; Lee UH; Lee JJ; Kwon B; Kwon BS; Park JW
J Immunol Methods; 2004 Mar; 286(1-2):187-201. PubMed ID: 15087232
[TBL] [Abstract][Full Text] [Related]
25. Functional humanization of an anti-CD30 Fab fragment for the immunotherapy of Hodgkin's lymphoma using an in vitro evolution approach.
Schlapschy M; Gruber H; Gresch O; Schäfer C; Renner C; Pfreundschuh M; Skerra A
Protein Eng Des Sel; 2004 Dec; 17(12):847-60. PubMed ID: 15708864
[TBL] [Abstract][Full Text] [Related]
26. Cloning, expression, and characterization of single-chain variable fragment antibody against mycotoxin deoxynivalenol in recombinant Escherichia coli.
Choi GH; Lee DH; Min WK; Cho YJ; Kweon DH; Son DH; Park K; Seo JH
Protein Expr Purif; 2004 May; 35(1):84-92. PubMed ID: 15039070
[TBL] [Abstract][Full Text] [Related]
27. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.
Poulaki V; Mitsiades CS; McMullan C; Fanourakis G; Negri J; Goudopoulou A; Halikias IX; Voutsinas G; Tseleni-Balafouta S; Miller JW; Mitsiades N
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):358-66. PubMed ID: 15623796
[TBL] [Abstract][Full Text] [Related]
28. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
Wu H; Nie Y; Huse WD; Watkins JD
J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
[TBL] [Abstract][Full Text] [Related]
29. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.
Scherf U; Benhar I; Webber KO; Pastan I; Brinkmann U
Clin Cancer Res; 1996 Sep; 2(9):1523-31. PubMed ID: 9816329
[TBL] [Abstract][Full Text] [Related]
31. A novel domain antibody rationally designed against TNF-alpha using variable region of human heavy chain antibody as scaffolds to display antagonistic peptides.
Qin W; Feng J; Li Y; Lin Z; Shen B
Mol Immunol; 2007 Mar; 44(9):2355-61. PubMed ID: 17125837
[TBL] [Abstract][Full Text] [Related]
32. Catalytically active Yersinia outer protein P induces cleavage of RIP and caspase-8 at the level of the DISC independently of death receptors in dendritic cells.
Gröbner S; Adkins I; Schulz S; Richter K; Borgmann S; Wesselborg S; Ruckdeschel K; Micheau O; Autenrieth IB
Apoptosis; 2007 Oct; 12(10):1813-25. PubMed ID: 17624595
[TBL] [Abstract][Full Text] [Related]
33. Mono and bivalent binding of a scFv and covalent diabody to murine laminin-1 using radioiodinated proteins and SPR measurements: effects on tissue retention in vivo.
Huang BC; Davern S; Kennel SJ
J Immunol Methods; 2006 Jun; 313(1-2):149-60. PubMed ID: 16750217
[TBL] [Abstract][Full Text] [Related]
34. Production and characterization of an active single-chain variable fragment antibody recognizing CD25.
Muramatsu H; Yoshikawa K; Hayashi T; Takasu S; Kawada Y; Uchida K; Sato S; Takahashi T; Saga S; Ueda R
Cancer Lett; 2005 Jul; 225(2):225-36. PubMed ID: 15978327
[TBL] [Abstract][Full Text] [Related]
35. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
[TBL] [Abstract][Full Text] [Related]
37. [Construction and expression of anti-tumor necrosis factor related apoptosis-inducing ligand receptor death receptor 5 chimeric antibody in eukaryotic cells].
Chen F; Guo YB; Liu SL; Zheng DX; Liu YX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Dec; 30(6):690-5. PubMed ID: 19180918
[TBL] [Abstract][Full Text] [Related]
38. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
[TBL] [Abstract][Full Text] [Related]
39. Stabilization and humanization of a single-chain Fv antibody fragment specific for human lymphocyte antigen CD19 by designed point mutations and CDR-grafting onto a human framework.
Kügler M; Stein C; Schwenkert M; Saul D; Vockentanz L; Huber T; Wetzel SK; Scholz O; Plückthun A; Honegger A; Fey GH
Protein Eng Des Sel; 2009 Mar; 22(3):135-47. PubMed ID: 19188138
[TBL] [Abstract][Full Text] [Related]
40. Monovalent single-chain Fv fragments and bivalent miniantibodies bound to vesicular stomatitis virus protect against lethal infection.
Kalinke U; Krebber A; Krebber C; Bucher E; Plückthun A; Zinkernagel RM; Hengartner H
Eur J Immunol; 1996 Dec; 26(12):2801-6. PubMed ID: 8977271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
